Series A · Enterprise software
Biolevate raises €30M Series A for international expansion
Biolevate raised €30 million in Series A financing co-led by RAISE France and Orange Ventures, bringing total funding to €36 million.
MSD Global Health Innovation Fund, Station F and existing investor EQT Ventures also participated.
The company plans to open a Boston office, deepen product capabilities and expand life-sciences deployments. At the announcement it reported more than a dozen enterprise customers in production and a 20-fold increase in annual recurring revenue over the prior 12 months.
Use of funds
Accelerate international expansion, including opening a Boston office, deepen product capabilities and scale life-sciences deployments.
Funding history
Series A · This round€30M